146 related articles for article (PubMed ID: 32847094)
1. Searching for Promoters to Drive Stable and Long-Term Transgene Expression in Fibroblasts for Syngeneic Mouse Tumor Models.
Antonova DV; Alekseenko IV; Siniushina AK; Kuzmich AI; Pleshkan VV
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847094
[TBL] [Abstract][Full Text] [Related]
2. Possibility for Transcriptional Targeting of Cancer-Associated Fibroblasts-Limitations and Opportunities.
Antonova DV; Zinovyeva MV; Kondratyeva LG; Sass AV; Alekseenko IV; Pleshkan VV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804861
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
[TBL] [Abstract][Full Text] [Related]
4. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
6. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
7. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
[TBL] [Abstract][Full Text] [Related]
8. Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.
Ginn SL; Fleming J; Rowe PB; Alexander IE
Hum Gene Ther; 2003 Aug; 14(12):1127-37. PubMed ID: 12908965
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
10. Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.
Yamada Y; Ishikawa T; Harashima H
Biomaterials; 2017 Aug; 136():56-66. PubMed ID: 28521201
[TBL] [Abstract][Full Text] [Related]
11. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
[TBL] [Abstract][Full Text] [Related]
12. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of the E4 adenoviral genes on viral and cellular promoters.
Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M
J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264
[TBL] [Abstract][Full Text] [Related]
14. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
[TBL] [Abstract][Full Text] [Related]
15. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.
Luo Y; Zhu D
Biomed Res Int; 2014; 2014():751397. PubMed ID: 24864258
[TBL] [Abstract][Full Text] [Related]
17. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
[TBL] [Abstract][Full Text] [Related]
18. E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors.
Armentano D; Smith MP; Sookdeo CC; Zabner J; Perricone MA; St George JA; Wadsworth SC; Gregory RJ
J Virol; 1999 Aug; 73(8):7031-4. PubMed ID: 10400804
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
[TBL] [Abstract][Full Text] [Related]
20. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
